TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

24.70$ +1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.00 0.00 0.00 0.81 0.87 4.90 0.77 1.41
0.00 0.96 1.06 2.21 3.61 4.45 5.67 4.47 0.23
0.00 -0.96 -1.06 -2.21 -2.81 -3.58 4.90 -3.69 1.19
0.45 0.96 1.06 2.21 6.03 4.45 5.67 4.47 4.14
0.16 0.34 0.40 0.63 0.89 1.25 1.51 1.35 1.15
0.66 0.34 0.40 0.63 3.30 1.25 7.18 1.35 5.07
-0.66 -1.30 -1.46 -2.84 -6.11 -4.83 -2.29 -5.05 -3.88
0.00 0.00 0.00 0.03 0.00 0.22 0.60 0.60 0.44
-0.67 -3.32 -1.53 -4.16 -5.77 -4.08 -1.70 -4.58 -0.81
0.04 -2.02 0.00 1.32 -0.46 0.05 0.02 0.00 –
-0.67 -3.28 -1.53 -4.16 -5.77 -4.13 -1.72 -4.58 -0.81
-0.66 -1.28 -1.40 -2.74 -3.58 -3.88 -1.32 -4.31 -0.30

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?